ATE213233T1 - Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit - Google Patents

Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit

Info

Publication number
ATE213233T1
ATE213233T1 AT94911704T AT94911704T ATE213233T1 AT E213233 T1 ATE213233 T1 AT E213233T1 AT 94911704 T AT94911704 T AT 94911704T AT 94911704 T AT94911704 T AT 94911704T AT E213233 T1 ATE213233 T1 AT E213233T1
Authority
AT
Austria
Prior art keywords
treatment
hiv disease
substituted
caprolactames
derivatives usable
Prior art date
Application number
AT94911704T
Other languages
English (en)
Inventor
Carl Nicholas Hodge
Christina Howard Fernandez
Prabhakar Kondaji Jadhav
Patrick Yuk-Sun Lam
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Application granted granted Critical
Publication of ATE213233T1 publication Critical patent/ATE213233T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT94911704T 1993-03-30 1994-03-28 Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit ATE213233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/040,324 US5663333A (en) 1992-10-22 1993-03-30 Substituted 1,4-diazapine caprolactams useful for treatment of HIV disease
PCT/US1994/003224 WO1994022840A1 (en) 1993-03-30 1994-03-28 Substituted caprolactams and derivatives thereof useful for treatment of hiv disease

Publications (1)

Publication Number Publication Date
ATE213233T1 true ATE213233T1 (de) 2002-02-15

Family

ID=21910379

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911704T ATE213233T1 (de) 1993-03-30 1994-03-28 Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit

Country Status (7)

Country Link
US (2) US5663333A (de)
EP (1) EP0691961B1 (de)
AT (1) ATE213233T1 (de)
AU (1) AU6415994A (de)
CA (1) CA2159442A1 (de)
DE (1) DE69429856D1 (de)
WO (1) WO1994022840A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753652A (en) * 1991-07-03 1998-05-19 Novartis Corporation Antiretroviral hydrazine derivatives
US5663333A (en) * 1992-10-22 1997-09-02 The Dupont Merck Pharmaceutical Company Substituted 1,4-diazapine caprolactams useful for treatment of HIV disease
US5683999A (en) * 1995-03-17 1997-11-04 The Dupont Merck Pharmaceutical Company Cyclic urea HIV protease inhibitors
ZA966885B (en) * 1995-08-22 1998-02-16 Du Pont Merck Pharma Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors.
US5849911A (en) * 1996-04-22 1998-12-15 Novartis Finance Corporation Antivirally active heterocyclic azahexane derivatives
US20040219516A1 (en) * 2002-07-18 2004-11-04 Invitrogen Corporation Viral vectors containing recombination sites
WO2006059801A1 (ja) * 2004-12-02 2006-06-08 Asubio Pharma Co., Ltd. ７員環化合物並びにその製造法および医薬用途
JP5118648B2 (ja) * 2005-12-29 2013-01-16 イミュファルマ・フランス・エスアー 疾患の処置および予防のための組成物および方法
US20080031951A1 (en) 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for the inhibition of phospholipase A2
KR20170129769A (ko) 2015-03-17 2017-11-27 리제너론 파아마슈티컬스, 인크. 아미노산 아실화 시약 및 이의 사용 방법
US10189864B2 (en) 2016-02-19 2019-01-29 Lawrence Livermore National Security, Llc Metal complexes based on a bis(2-pyridylmethyl)amine-based scaffold and methods of making the same
US10112912B2 (en) * 2016-03-02 2018-10-30 Lawrence Livermore National Security, Llc Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT355025B (de) * 1974-11-29 1980-02-11 Sandoz Ag Verfahren zur herstellung neuer 5-amino-7- phenyl-2,3-dihydro-1h-1,4-diazepine
US4002612A (en) * 1976-04-05 1977-01-11 Morton-Norwich Products, Inc. 1-(3,4-Dichlorobenzyl)hexahydro-1,3-diazepin-2(1H)-one
US4190571A (en) * 1977-09-21 1980-02-26 The B. F. Goodrich Company Substituted 2-keto-1,4-diazacycloalkanes and UV-light-stabilized compositions containing them
US4466916A (en) * 1979-10-26 1984-08-21 The B. F. Goodrich Company Substituted 2-keto-1,4-diazacycloalkanes
EP0559793A1 (de) * 1990-11-30 1993-09-15 Smithkline Beecham Corporation Hiv-protease inhibitoren
US5663333A (en) * 1992-10-22 1997-09-02 The Dupont Merck Pharmaceutical Company Substituted 1,4-diazapine caprolactams useful for treatment of HIV disease
AU5359594A (en) * 1992-10-22 1994-05-09 Du Pont Merck Pharmaceutical Company, The Substituted caprolactams and derivatives thereof useful for treatment of aids
JPH09500120A (ja) * 1993-07-14 1997-01-07 チバ−ガイギー アクチェンゲゼルシャフト 環式ヒドラジン化合物

Also Published As

Publication number Publication date
US5663333A (en) 1997-09-02
DE69429856D1 (de) 2002-03-21
EP0691961B1 (de) 2002-02-13
EP0691961A1 (de) 1996-01-17
US5877170A (en) 1999-03-02
WO1994022840A1 (en) 1994-10-13
AU6415994A (en) 1994-10-24
CA2159442A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
UA41297C2 (uk) Похідні індолу, фармацевтична композиція і спосіб лікування
ATE429210T1 (de) Orale flüssige zusammensetzungen
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
EA199901031A1 (ru) Производные бензимидазола
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
YU12097A (en) 6-phenilpyridyl-2-amine derivatives
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
DK0705100T3 (da) Terapeutiske substituerede guanidiner
SE9802729D0 (sv) Novel Compounds
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
ATE188873T1 (de) Tris-platin-komplexe
NO20010940D0 (no) TAN-1057 derivater
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE187956T1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties